iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · IEX Real-Time Price · USD
3.360
+2.210 (192.17%)
At close: Mar 27, 2024, 4:00 PM
4.320
+0.960 (28.57%)
Pre-market: Mar 28, 2024, 8:44 AM EDT

iBio, Inc. Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Year 2023202220212020201920182017201620152014 2013 - 2009
Net Income
-65.01-50.39-23.47-38.26-17.85-16.37-14.62-9.76-6.63-3.67
Upgrade
Depreciation & Amortization
1.383.792.412.241.751.711.680.940.360.36
Upgrade
Share-Based Compensation
4.394.381.590.390.240.771.011.250.911.08
Upgrade
Other Operating Activities
28.84.74-10.860.471.630.15-1.32-0.490.62-1.89
Upgrade
Operating Cash Flow
-30.44-37.48-30.06-13.35-13.98-13.48-13.16-8.07-4.73-4.12
Upgrade
Capital Expenditures
-3.14-11.63-5.16-1.15-0.99-1.08-1.59-0.07-0.22-0.26
Upgrade
Acquisitions
-0.69000000000
Upgrade
Change in Investments
10.846.5-19.820000000
Upgrade
Other Investing Activities
---1.5-------
Upgrade
Investing Cash Flow
7.01-5.13-26.48-1.15-0.99-1.08-1.59-0.07-0.22-0.26
Upgrade
Share Issuance / Repurchase
11.450.0883.8868.823.8122.7107.2310.873.58
Upgrade
Debt Issued / Paid
-9.15-6.15-0.33-1.46-0.2-0.18-0.17-0.5700
Upgrade
Other Financing Activities
--0.05-4.71-2.17-0.16-0.13-15--0.03
Upgrade
Financing Cash Flow
2.3-6.1378.8465.193.4522.41-0.1721.6610.873.55
Upgrade
Exchange Rate Effect
0.030-0-0-0-00-0-0.020
Upgrade
Net Cash Flow
-21.09-48.7322.2950.69-11.517.85-14.9313.525.9-0.82
Upgrade
Free Cash Flow
-33.57-49.11-35.23-14.5-14.97-14.56-14.76-8.14-4.94-4.38
Upgrade
Free Cash Flow Margin
--2606.69%-1485.70%-885.16%-741.58%-3279.05%-3745.18%-858.65%-266.88%-2134.15%
Upgrade
Free Cash Flow Per Share
-54.84-112.63-90.03-115.45-395.36-684.74-827.97-502.62-345.48-347.39
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).